Recombinant receptor activator of nuclear factor κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in vitro and in vivo

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 631-638

Spandidos Publications

Access to resources Recommend Favorite

Recombinant human vascular endothelial growth factor receptor 1 effectively inhibits angiogenesis in vivo

By                

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3432-3438

Spandidos Publications

Access to resources Recommend Favorite

Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 54-72

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings

By Milas L.   Mason K. A.   Ang K. K.  

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 539-545

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia and Recovery in Growth Cartilage in Vivo

By Kember N.F.  

International Journal of Radiation Biology, Vol. 13, Iss. 4, 1968-04 ,pp. : 387-390

Informa Healthcare

Access to resources Recommend Favorite